BPC-157 treatment in animal models reversed the congestive heart failure that developed after doxorubicin exposure
"Irrespective of what happens in January or through 2026, we're committed to supporting patients on semaglutide and that includes both Ozempic and Wegovy and to continuing to make it available," he said, noting that the company will provide "financial and savings support" to some patients who don't have insurance coverage and don't want to switch to a generic version
Because when care adapts to your life, your progress lasts
Once the weight is lost, it should not come back, provided you maintain a healthy diet and active lifestyle
Human nature being what it is , even motivated patients struggle to make and sustain lifestyle changes on their own especially while dealing with medication side effects
Yash Vora is a financial writer with the Informed InvestoRR team at Equentis